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Abstract 
Chikungunya virus is an arthropod-borne alphavirus that, in recent years, has presented an 
increased threat to human populations as the Aedes aegypti mosquitos which carry it have 
experienced resurgence in their population and by genetic adaptation to a new vector: aedes 
albopictus.  Chikungunya virus contains three glycoproteins (E1, E2, E3).  E2 contains two N-
linked glycosylation sites (N263, N345), and E1 contains a single site (N141).  These glycans 
may be important for modulating host interferon response and tropism, as has been shown for 
other alphaviruses.  This thesis seeks to identify the primary oligosaccharide at each 
glycosylation site by endoglycosidase digestion and SDS-PAGE.  Furthermore, the experiments 
described herein aim to determine the effect of the removal of either or both of the N-linked 
glycans of E2 on its ability to bind Human Prohibitin-1, a previously identified receptor. 
 
Introduction 
 Chikungunya, an arthropod-borne virus of the family Togaviridae; genus alphavirus, is 
an enveloped, positive sense RNA virusi.  CHIKV has become increasingly important to study as 
efforts to control these vectors have decreased, humans have encroached on the tropical habitats 
of the vectors, world travel has increased, and global warming has expanded the habitats of its 
vectors, Aedes aegypti and Aedes albopictus, which are native to tropical to subtropical climates 
and temperate climates, respectively.  In the 20th century, chikungunya (CHIKV) was confined to 
Africa, Asia, and the Indian subcontinent; however, several large outbreaks since 1999 have 
occurred, including outbreaks in the Democratic Republic of the Congo (1999-2000), Gabon 
(2007), La Réunion (2005-2006), and South-East Asia (2005-2007), as well as the first reported 
cases of transmission in Europeii.  Currently, no specific treatment or vaccine exists for CHIKV. 
 The genome of CHIKV is single stranded, positive-sense RNA.  It is organized into two 
open reading frames that encode the nonstructural and structural polyproteins of the virus.  The 
first contains the four nonstructural proteins, which are responsible for the production of both 
negative and positive sense (subgenomic and full length, respectively) RNA.  This is used as the 
template for the production of mRNA for the viral structural proteins.  The structural proteins 
consist of capsid, two major glycoproteins, and accessory proteins. The genome possesses a 5’ 7-
methylguanosine cap and is polyadenylated at the 3’ endiii. 
 Sequence analysis has identified a total of three N-linked glycosylation sites in the E1 
and E2 glycoproteins: two in E2, located at N263 and N345, and one in E1 at N141. These sites 
are demarcated by the sequon Asn-X-Thr or Asn-X-Ser, where X can be any amino acid except 
for Proiv.  A sugar precursor is added to the Asn residue in the lumen of the ERv.  This precursor 
core is then digested by various exoglycosidases as the polypeptide is transported through the 
Golgi.  This process leads to the production of the predominant oligosaccharide of one of three 
major classes of N-linked glycosylation: high-mannose, hybrid, and complexvi.  While 
mammalian cells can produce each of the three types, arthropods do not produce complex N-
linked glycansvii.   
N-linked glycans have been shown to have an important role in alphavirus biology.  
Previous work in the Heise lab has demonstrated that CHIKV lacking one or both N-linked 
glycans of E2 retained its ability to replicate but was severely attenuated in its ability to induce 
swelling and joint inflammation of infected miceviii.  N-linked glycans have also been shown to 
modulate alphavirus tropism through interactions with C-type lectinsix and to modulate host 
Type 1 interferon responsex.  Finally, it was shown that Ross River virus N-Linked glycans 
promote binding of mannose-binding lectin, which leads to virus-induced diseasexi. 
 Prohibitin-1 is a protein that has been identified as a potential receptor for CHIKV, and it 
has been shown to specifically bind to the E2 glycoprotein by co-immunoprecipitationxii.  In 
humans, Prohibitin-1 dimerizes with Prohibitin-2.  Due to its antiproliferative properties and role 
in apoptosis, prohibitin is very well conserved throughout eukaryotic cellsxiii,xiv which are much 
like the dimerized prohibitin protein. Prohibitin has also been identified as a receptor protein for 
Dengue-2 in insect cellsxv.  As E2 is known to have a receptor binding role in CHIKV, it is of 
interest to study the effects of N-linked glycosylation of this protein on this interaction.   
 In order to study this interaction, a technology that allows for the confirmation of 
suspected protein interactions using split fluorescent proteins, bimolecular fluorescence 
complementation (BiFC), will be employed. The BiFC constructs described here reconstitute a 
functional tripartite GFP moleculexvi.  The three GFP fragments are the nine N-terminal beta 
strands of GFP, the 10th strand, and the 11th strand.  The tenth and eleventh strand are added in 
frame to the proteins of interest in various orientations by a high-glycine linker region.  If the 
proteins of interest interact in such a way that one of the orientations places the 10th and 11th 
strands in close proximity in the cytoplasm, then the three pieces will reconstitute the fluorescent 
protein. 
 The first goal of this thesis is to identify the predominant oligosaccharide at each of the 
three N-linked glycosylation sites within the glycoproteins of Chikungunya virus, which will be 
done by endoglycosidase digestion and Western blotting.  The second is to confirm a specific 
E2/PHB-1 interaction using GFP-based bimolecular fluorescence complementation (BiFC) and 
to study the importance of the N-linked glycans of E2 in E2/PHB-1 binding. 
  
Materials and Methods 
Glycoprotein Expression Construct Design 
Standard PCR based molecular cloning methodologies were used to introduce asparagine to 
glutamine mutations in at the correct sites (E2 N263Q, E2 N345Q, E2 N263;345Q [DM], and E1 
N141Q) in full length CHIKV SL15649 (constructs provided by Charles McGee).  These 
glycoproteins, as well as the wild type proteins, were PCR-amplified from full length clones 
using primer pairs that incorporated a 3’ FLAG tag for the E2 constructs or a 3’ V5 tag for the 
E1 constructs and 5’ Nhe1/3’ BamH1 sites.  These amplicons were then cloned into pcDNA3.1 
(Invitrogen) for mammalian expression or pMIB-A Δ(Honeybee melittin secretion signal) 
(Invitrogen) for expression in arthropod cells. Constructs were verified by PCR, restriction 
digest, and sequencing. 
 
Tripartite Split-GFP Construct Designxvii 
The BiFC constructs reconstitute a tripartite GFP molecule.  The entirety of the optimized GFP 
sequence was produced by IDT.  The three constructs are as follows. GFP1-9 encoding the first 
nine beta strands of GFP was PCR amplified from the IDT-GFP and cloned into pcDNA3.1. 
Four cassettes were designed for ease of future cloning: 5’ GFP-10, 3’ GFP-10, 5’ GFP-11, and 
3’ GFP-11 with a multiple cloning site present at the junction of the linker (5’ linker: 
GTDVGSGGGSHMGGG; 3’ linker: GSGGGSGGGSTS) and the gene of interest.  Each of the 
E2 glycan mutants described above and Prohibitin-1 were cloned into this cassette in pcDNA3.1. 
 
Cell Culture 
293T, a line of human embryonic kidney cells selected for high transfectability, cells were grown 
in 10 cm2 dishes in DMEM High Glucose [Gibco] supplemented with 10% fetal bovine serum 
[Atlanta Biologicals], 1% Penicillin/Streptomycin, and 1% L-Glutamine at 37oC with 5% CO2.  
Ae. albopictus (C6/36) cells were grown in T-75 flasks in 80% L-15 Media [Cellgro], 10% 
Triptose phosphate buffer, 10% fetal bovine serum [Atlanta Biologicals], 100 units/mL Pencillin, 
100 units/mL Streptomycin, and 1% L-Glutamine at 28oC without CO2. 
 
Plasmid Transfection 
Six-well plates were seeded with 293T cells 24 hours before transfection at a density of 1 x 106 
cells per well in 2 mL maintenance per well.  At the time of transfection, media was replaced 
with serum-free media.  30 μg plasmid was added 125μL 1M CaCl2 and the volume was brought 
up to 500 μL with ddH2O.  500 μL 2X BES (6.7 mL ddH2O, 2 mL 1.4M NaCl, 1 mL 0.5M BES 
[Sigma], 100 μL 150 mM Na2HPO4, ~220 μL 1N NaOH, pH 6.95, filter sterilized) was added 
dropwise with pulse vortexing. The entire mix was incubated for 45 min. at room temperature 
then 200 μL was added dropwise to each well.  600 μL FBS was added after 90 minutes and 
media was changed the next day.  After 48 hours, cells were lysed with 1X RIPA buffer with 
added protease inhibitor, centrifuged, and the supernatant collected. 
 
Six-well plates were seeded with 5 x 106 C6/36 cells per well 24 hours before transfection in 2 
mL maintenance media per well.  The Reagent:DNA complex was prepared as follows: X-
tremeGene HP (Roche Applied Science) warmed to room temperature and pulse vortexed, 4 μg 
plasmid DNA added to 200 μL empty L-15 media, 16 μL transfection reagent added to reaction, 
mixed, and incubated at room temperature for 15-30 minutes.  The reaction mix was added 
dropwise to cells.  After 48 hours, cells were lysed with 1X RIPA buffer with added protease 
inhibitor, centrifuged, and the supernatant collected. 
 
Endoglycosidase Digestions, SDS-PAGE and Western Blotting 
Protein concentration was determined in each sample by Bradford assay.  60 μg protein was 
diluted to 3 μg/μL and digested with 10 U PNGase F or Endo H (New England Biolabs) 
overnight at 37oC.  10 μL of this reaction (~30 μg protein) was analyzed by sodium dodecyl 
sulfate (SDS)-15% polyacrylamide gel electrophoresis (PAGE) and subjected to Western blot 
analysis using anti-CHIKV mouse immune ascites fluid followed by incubation with an anti-
mouse horseradish-peroxidase-conjugated secondary antibody.   Protein bands were visualized 
by ECL Plus (Amersham) immunofluorescence and developed on Amersham Hyperfilm ECL 
film. A titration against 18 μg E2 or E1 using anti-Chikungunya mouse serum was also 
performed in order to determine the efficacy of using this reagent to detect the major 
glycoproteins.   
 
Coomassie Stainingxviii 
Gels were fixed in three volumes of 50% methanol, 10% acetic acid, 40% water fixing solution 
at room temperature for two hours on an orbital shaker.  Fixing solution was removed and gel 
was covered in staining solution (50% methanol, 0.05% Coomassie brilliant blue R-250, 10% 
acetic acid, 40% water) for four hours with gentle agitation.  Staining solution was removed and 
gel was rinsed with 50 mL fixing solution.  Fixing solution was removed and gel was covered 
with destaining solution (5% methanol, 7% acetic acid, 88% water) for two hours at room 


In order to evaluate this, several constructs will be produced that should allow this to be 
explored. First, wild-type E2 and E1 will be fused to GFP in sequence and transfected into 293T 
cells.  If GFP, and, by assumption, the glycoproteins, are successfully produced, the transfected 
cells will be detectable by fluorescent microscopy.   
Second, the entire casette containing E3 to E1 will be placed in an expression construct.  
This will be transfected as above and tested by SDS-PAGE, Western blotting, and Coomassie 
staining to determine whether wild-type E2 and E1 are successfully being expressed in this way.  
If so, then the predominant oligosaccharide will be characterized as described above.  Several 
monoclonal antibodies against CHIKV E2 and E1 will also be tested against E2 and E1 produced 
in this way.  
Third, the Chikungunya 181/25 vaccine strain will be produced from molecular clones 
containing the various combinations of glycosylation site ablations by first transcribing the viral 
RNA in vitro followed by electroporating the RNA into BHK cells. This analysis will then be 
repeated with BHK and C6/36 produced virus.  
Figure 2;  Coomassie stain of SDS-15%-PAGE gel containing lysates of 293T cells transfected with expression plasmids of 
each protein listed above each lane.  For each CHIKV protein, three lanes were run: undigested, PNGase F digested, and 
EndoH digested (left to right).  The 36 kDa band in each PNGase F lane is the endoglycosidase. 
 
Finally, this casette (E3 to E1) will be placed in a lentiviral vector for expression.  
Similarly to the above expression constructs, the expression of wild-type E2 and E1 will first be 
analyzed by SDS-PAGE, Western blotting, and Coomassie staining, followed by identification of 
the predominant oligosaccharide if expression if successful.  
In conclusion, it appears that the CHIKV E2 and E1 glycoproteins were not successfully 
expressed by these constructs, and new approaches will be necessary to express the proteins in 
order to determine the predominant oligosaccharides present at each N-Linked glycosylation site.  
Once the proteins are successfully produced, the BiFC constructs will be made and experiments 
regarding the E2/Human Prohibitin-1 interaction and the role of glycans in this interaction can 
begin. 
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